Company page

Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc. (ticker: CYCN) is a public company based in the United States, with a market capitalization of approximately $13.64 million. The company focuses on developing innovative therapies for central nervous system disorders. Cyclerion is committed to advancing its research and clinical programs to address unmet medical needs in this area.